Minimum inhibitory concentration and killing properties of rifampicin against canine Staphylococcus pseudintermedius isolates from dogs in the southeast USA

Veterinary Dermatology
Karen K HoAmelia G White

Abstract

Meticillin-resistant (MR) staphylococcal pyoderma in dogs has led to increased use of alternate antibiotics such as rifampicin (RFP). However, little information exists regarding its pharmacodynamics in MR Staphylococcus pseudintermedius. To determine the minimum inhibitory concentration (MIC) and killing properties of RFP for canine Staphylococcus pseudintermedius isolates. The MIC of RFP was determined using the ETEST® for 50 meticillin-susceptible (MS) and 50 MR S. pseudintermedius isolates collected from dogs. From these isolates, two MS isolates (RFP MIC of 0.003 and 0.008 μg/mL, respectively) and two MR isolates (RFP MIC of 0.003 and 0.012 μg/mL, respectively) were subjected to time-kill studies. Mueller-Hinton broth was supplemented with RFP at 0, 0.5, 1, 2, 4, 8, 16 and 32 times the MIC for 0, 2, 4, 10, 16 and 24 h. The number of viable colony forming units in each sample was determined using a commercial luciferase assay kit. The MIC50 and MIC90 were the same for MS and MR isolates, at 0.004 μg/mL and 0.008 μg/mL, respectively. Rifampicin kill curves were not indicative of concentration-dependency, suggesting time-dependent activity. Two isolates (MS 0.003 and 0.008 μg/mL) exhibited bacteriostatic activity, whereas two...Continue Reading

References

Oct 1, 1986·Antimicrobial Agents and Chemotherapy·E TuomanenA Tomasz
May 1, 1985·Reviews of Infectious Diseases·S Handwerger, A Tomasz
Sep 1, 1973·Antimicrobial Agents and Chemotherapy·M C Lobo, G L Mandell
Feb 1, 1969·The Journal of Infectious Diseases·C M KuninH Wood
Jul 1, 1983·Reviews of Infectious Diseases·W Wehrli
Jun 1, 1984·The Journal of Antimicrobial Chemotherapy·J E KapusnikM A Sande
Jun 1, 1993·Journal of Veterinary Pharmacology and Therapeutics·C W KohnS Wallace
Jun 23, 2001·The Journal of Antimicrobial Chemotherapy·A P MacGowan, R Wise
Mar 5, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·G A Pankey, L D Sabath
Mar 20, 2004·Nature Reviews. Microbiology·George L Drusano
Sep 25, 2004·Antimicrobial Agents and Chemotherapy·Samuel A ShelburneRichard J Hamill
Sep 19, 2007·Antimicrobial Agents and Chemotherapy·Paul G AmbroseHenry S Heine
Jul 29, 2008·The Journal of Antimicrobial Chemotherapy·Robert SauermannMarkus Zeitlinger
Aug 21, 2008·The Journal of Antimicrobial Chemotherapy·Marta SousaMarta Boffito
Sep 2, 2008·Veterinary Microbiology·Luc A DevrieseFreddy Haesebrouck
Feb 28, 2009·Veterinary Microbiology·J Scott Weese, Engeline van Duijkeren
Jan 13, 2010·Clinical Microbiology Reviews·Graeme N Forrest, Kimberly Tamura
Sep 21, 2011·The Journal of Antimicrobial Chemotherapy·Engeline van DuijkerenUNKNOWN Scientific Advisory Group on Antimicrobials (SAGAM)
Jan 31, 2012·Joint, Bone, Spine : Revue Du Rhumatisme·Guillaume Coiffier, Jean-David Albert
Jun 12, 2012·Veterinary Dermatology·Kristina Kadlec, Stefan Schwarz
Jun 29, 2012·American Journal of Veterinary Research·Mark G Papich
Apr 16, 2016·Nature Reviews. Microbiology·Asher BraunerNathalie Q Balaban
Feb 12, 2017·Science·Irit Levin-ReismanNathalie Q Balaban
Sep 6, 2017·The Journal of Infection·Chun-Yuan LeePo-Ren Hsueh
Dec 31, 2017·International Journal of Antimicrobial Agents·Yu Mi WiRobin Patel

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.